Biosimilar Awareness, Access, and Savings Continue to Grow


Biosimilar Savings and Their Price: BPCIA Turns Ten

October 6-7 | Virtual

This year marks the 10th Anniversary of the Biosimilars Price Competition and Innovation Act (BCPIA), which created a biosimilars approval pathway in the US with the goal of increasing access to safe, effective, and cost-effective biological treatment options for patients.

To date, significant progress has been made in the science and regulation of biosimilar development and approval, and awareness and educational efforts are increasing prescriber and patient confidence and uptake. The challenges have been and continue to be complex, interrelated, and best addressed by stakeholder collaboration, not only within the US but across global regions.

At the DIA 2020 Biosimilars Conference, manufacturers, regulators, payers, prescribers, and patients will come together to envision the biosimilars landscape of the next 5 years and to share perspectives on what success and equilibrium will look like.

What Our Users Think About Us

Mark Turin

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words which don't look even slightly believable.